INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
BE-TABS PYRIDOXINE HYDROCHLORIDE

SCHEDULING STATUS:
S0

PROPRIETARY NAME
(and dosage form):

BE-TABS PYRIDOXINE HYDROCHLORIDE

COMPOSITION:
Each tablet contains:
Pyridoxine Hydrochloride 25 mg
Sugar Free.

PHARMACOLOGICAL CLASSIFICATION:
A 22.1.4 Vitamins, other

PHARMACOLOGICAL ACTION:
Vitamin Supplement.

INDICATIONS:
It is used for the prevention and treatment of pyridoxine hydrochloride deficiency.

CONTRA-INDICATIONS:
There are no known contra-indications for pyridoxine hydrochloride.

DOSAGE AND DIRECTIONS FOR USE:
For the treatment of anaemia induced by pyridoxine deficiency in adults, the dosage is 50 to 150 mg in divided doses.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Pyridoxine reduces the effects of levodopa.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
In man, oral doses up to 1000 mg daily have not caused adverse reactions.

IDENTIFICATION:
White, round tablet, 6,4 mm in diameter.

PRESENTATION:
In bottles of 100, 250, 500, 1000 and 5000 tablets.

STORAGE INSTRUCTIONS:
Store in a cool dry place below 25°C. Protect from light.
KEEP OUT OF REACH OF CHILDREN.

APPLICATION NUMBER:
T 1200(Act 101,1965)

NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE OF REGISTRATION:
BE-TABS PHARMACEUTICALS (PTY) LTD.
14 Lautre Road
Stormill Ext. 1
Roodepoort
1724
SOUTH AFRICA

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
12/09/1985
CODE: IPD/7       

        JET PRINTERS 6/2003
Updated on this site: February 2006
Source: Hospital Pharmacy

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2006